Optimal cytoreduction in stage IV ovarian carcinoma -: In reply

被引：0
|
作者：
Bonnefoi, H [1 ]
Gore, ME
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
[2] Royal Marsden Hosp, London SW3 6JJ, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1999年 / 17卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：3004 / 3004
页数：1
相关论文
共 50 条
  • [31] Prerequisites to improve surgical cytoreduction in FIGO stage III/IV epithelial ovarian cancer and subsequent clinical ramifications
    Diederick de Jong
    Amudha Thangavelu
    Timothy Broadhead
    Inga Chen
    Dermot Burke
    Richard Hutson
    Racheal Johnson
    Angelika Kaufmann
    Peter Lodge
    David Nugent
    Aaron Quyn
    Georgios Theophilou
    Alexandros Laios
    Journal of Ovarian Research, 16
  • [32] Prerequisites to improve surgical cytoreduction in FIGO stage III/IV epithelial ovarian cancer and subsequent clinical ramifications
    de Jong, Diederick
    Thangavelu, Amudha
    Broadhead, Timothy
    Chen, Inga
    Burke, Dermot
    Johnson, Racheal
    Hutson, Richard
    Kaufmann, Angelika
    Lodge, Peter
    Nugent, David
    Quyn, Aaron
    Theophilou, Georgios
    Laios, Alexandros
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [33] Residual disease after primary cytoreduction in stage IIIC ovarian cancer; is aggressive cytoreduction worth it?
    Wallace, S.
    Kumar, A.
    Mc Gree, M.
    Weaver, A.
    Cliby, W.
    GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 206 - 206
  • [34] Can the preoperative HE4 level predict optimal cytoreduction in patients with advanced ovarian carcinoma?
    Angioli, Roberto
    Plotti, Francesco
    Capriglione, Stella
    Aloisi, Alessia
    Montera, Roberto
    Luvero, Daniela
    Miranda, Andrea
    Cafa, Ester Valentina
    Damiani, Patrizio
    Benedetti-Panici, Pierluigi
    GYNECOLOGIC ONCOLOGY, 2013, 128 (03) : 579 - 583
  • [35] Stage IV micropapillary serous ovarian carcinoma: A report of three cases
    Kim, YW
    Srodon, M
    Bristow, RE
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2005, 24 (03) : 235 - 238
  • [36] Stage IV Small Bowel Carcinoma Mimicking Advanced Ovarian Cancer
    Dizon, Don S.
    Perez, Kimberly
    DiSilvestro, Paul
    Taneja, Charu
    Ilson, David
    AMERICAN SURGEON, 2009, 75 (09) : 864 - 865
  • [37] Cited rationale for variance in the use of primary intraperitoneal chemotherapy following optimal cytoreduction for stage III ovarian carcinoma at a high intraperitoneal chemotherapy utilization center
    Schlappe, Brooke A.
    Mueller, Jennifer J.
    Zivanovic, Oliver
    Gardner, Ginger J.
    Roche, Kara Long
    Sonoda, Yukio
    Chi, Dennis S.
    O'Cearbhaill, Roisin E.
    GYNECOLOGIC ONCOLOGY, 2016, 142 (01) : 13 - 18
  • [38] Secondary cytoreduction surgery for recurrent epithelial ovarian cancer - In reply
    Tay, EH
    Grant, PT
    Gebski, V
    Hacker, NF
    OBSTETRICS AND GYNECOLOGY, 2002, 100 (06): : 1360 - 1360
  • [39] Is surgical cytoreduction for stage IV pancreatic neuroendocrine tumors justifiable?
    Wang, Yi-Zarn
    McCord, Elizabeth
    Stevens, Melissa
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (04) : E98 - E98
  • [40] Is Surgical Cytoreduction for Stage IV Pancreatic Neuroendocrine Tumors Justifiable?
    Wang, Yi-Zarn
    McCord, Elizabeth
    Stevens, Melissa Aycock
    Diebold, Anne
    Ramirez, Robert A.
    Boudreaux, J. Philip
    Woltering, Eugene A.
    PANCREAS, 2016, 45 (03) : 485 - 485
12345